Euphillin (R) retard (EN) is a slow-release preparation of theophylline marketed in Indonesia. The usual dose for patients with chronic bronchial asthma is 1 tablet twice daily. Information on the steady-state serum concentration of theophylline after ER administration is still lacking. This information is important because theophylline has a narrow margin of safety and a large inter-and intra-…